Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry

Blood

Volumn 103, Issue 5, 2004, Pages 1586-1594

  Markovic, Ingrid ^a   Stantchev, Tzanko S ^b   Fields, Karen H ^b   Tiffany, Linda J ^b   Tomiç, Melanija ^b   Weiss, Carol D ^b   Broder, Christopher C ^b   Strebel, Klaus ^b   Clouse, Kathleen A ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; DISULFIDE; GLYCOPROTEIN GP 120; PROTEIN DISULFIDE ISOMERASE; THIOL DERIVATIVE;

ANIMAL CELL; ARTICLE; CATALYST; CELL FUSION; CELL MEMBRANE; COMPLEX FORMATION; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; T LYMPHOCYTE; VIRION; VIRUS ENVELOPE; VIRUS INFECTION;

EID: 1442283560     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-05-1390     Document Type: Article

References (44)

1. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol. 1999;17:657-700.
2. Doms RW, Moore JP. HIV-1 membrane fusion. Targets of opportunity. J Cell Biol. 2000;151:F9-F14.
3. Eckert DM, Kim PS. Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem. 2001;70:777-810.
4. Ryser HJ, Levy EM, Mandel R, DiSciullo GJ. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc Natl Acad Sci U S A. 1994;91:4559-4563.
5. Fenouillet E, Barbouche R, Courageot J, Miquelis R. The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding. J Infect Dis. 2001;183:744-752.
6. Gallina A, Hanley TM, Mandel R, et al. Inhibitors of protein disulfide isomerase (PDI) prevent cleavage of disulfide bonds in receptor-bound gp120 and prevent HIV-1 entry. J Biol Chem. 2002;277:50579-50588.
7. Barbouche R, Miquelis R, Jones IM, Fenouillet E. Protein disulfide isomerase-mediated reduction of two disulfide bonds of HIV Env gp120 occurs post CXCR4 binding and is required for fusion. J Biol Chem. 2003;278:3131-3136.
8. Ferrari DM, Soling HD. The protein disulphide-isomerase family: unravelling a string of folds. Biochem J. 1999;339(Pt 1):1-10.
9. Turano C, Coppari S, Altieri F, Ferraro A. Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol. 2002;193:154-163.
10. Terada K, Manchikalapudi P, Noiva R, et al. Secretion, surface localization, turnover, and steady state expression of protein disulfide isomerase in rat hepatocytes. J Biol Chem. 1995;270:20410-20416.
11. Markovic I, Pulyaeva H, Sokoloff A, Chernomordik LV. Membrane fusion mediated by baculovirus gp64 involves assembly of stable gp64 trimers into multiprotein aggregates. J Cell Biol. 1998;143:1155-1166.
12. Locker JK, Griffiths G. An unconventional role for cytoplasmic disulfide bonds in vaccinia virus proteins. J Cell Biol. 1999;144:267-279.
13. Sanders DA. Sulfhydryl involvement in fusion mechanisms. Subcell Biochem. 2000;34:483-514.
14. Earl PL, Sugiura W, Mantefiori DC, et al. Immunogenicity and protective efficacy of oligameric human immunodeficiency virus type 1 gp140. J Virol. 2001;75:645-653.
15. De Rosny E, Vassell R, Wingfield PT, Wild CT, Weiss CD. Peptides corresponding to the heptad repeat motifs in the transmembrane protein (gp41) of human immunodeficiency virus type-1 elicit antibodies to receptor-activated conformations of the envelope glycoprotein. J Virol. 2001;75:8859-8863.
16. Abacioglu YH, Fouts TR, Laman JD et al. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies. AIDS Res Hum Retroviruses. 1994;10:371-381.
17. Weiss CD, White JM. Characterization of stable Chinese hamster ovary cells expressing wildtype, secreted, and glycosylphosphatidylinositol-anchored human immunodeficiency virus type 1 envelope glycoprotein. J Virol. 1993;67:7060-7066.
18. Landau NR, Littman DR. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J Virol. 1992;66:5110-5113.
19. Deng H, Liu R, Ellmeier W, et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature. 1996;381:661-666.
20. Hoffman AD. Characterization of the AIDS associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology. 1985;147:326-335.
21. Markovic I, Leikina E, Zhukovsky M, Zimmerberg J, Chernomordik LV. Synchronized activation and refolding of influenza hemagglutinin in multimeric fusion machines. J Cell Biol. 2001;155:833-844.
22. Ono A, Freed EO. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc Natl Acad Sci U S A. 2001;98:13925-13930.
23. Roth RA. Bacitracin: an inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase. Biochem Biophys Res Commun. 1981;98:431-438.
24. Mandel R, Ryser HJ, Ghani F, et al. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci U S A. 1993;90:4112-4116.
25. Lapham CK, Ouyang J, Chandrasekhar B, Nguyen NY, Dimitrov DS, Golding H. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines. Science. 1996;274:602-605.
26. Xiao X-D, Wu L-J, Stantchev TS, et al. Constitutive cell surface association between CD4 and CCR5. Proc Natl Acad Sci U S A. 1999;96:7496-7501.
27. Millan J, Cerny J, Horejsi V, Alonso MA. CD4 segregates into specific detergent-resistant T-cell membrane microdomains. Tissue Antigens. 1999;53:33-40.
28. Kozak SL, Heard JM, Kabat D. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J Virol. 2002;76:1802-1815.
29. Manes S, del Real G, Lacalle RA, et al. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep. 2000;1:190-196.
30. Nguyen DH, Hildreth JE. Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J Virol. 2000;74:3264-3272.
31. Dimitrov DS. Cell biology of virus entry. Cell. 2000;101:697-702.
32. Chen J, Lee KH, Steinhauer DA, Stevens DJ, Skehel JJ, Wiley DC. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell. 1998;95:409-417.
33. Futami J, Tada H, Seno M, Ishikami S, Yamada H. Stabilization of human Rnase 1 by introduction of a disulfide bond between residues 4 and 118. J Biochem (Tokyo). 2000;128:245-250.
34. Nemeth A, Kamondi S, Szilagyi A, Magyar C, Kovari Z, Zavodszky P. Increasing the thermal stability of cellulase C using rules learned from thermophilic proteins: a pilot study. Biophys Chem. 2002;96:229-241.
35. Carr CM, Chaudhry C, Kim PS. Influenza hemagglutinin is spring-loaded by a metastable native conformation. Proc Natl Acad Sci U S A. 1997;94:14306-14313.
36. Carr CM, Kim PS. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 1993;73:823-832.
37. Matthias LJ, Yam P-T, Jiang X-M, et al. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nat Immunol. 2002;3:727-732.
38. Weber T, Zemelman BV, McNew JA, et al. SNAREpins: minimal machinery for membrane fusion. Cell. 1998;92:759-772.
39. Lundblad RL. Chemical Reagents for Protein Modification. The Modification of Cysteine. Boca Raton, FL: CRC Press;1991.
40. Percherancier Y, Lagane B, Planchenault T, et al. HIV-1 entry into T-cells is not dependent on CD4 and CCR5 localization to sphingolipid-enriched, detergent-resistant, raft membrane domains. J Biol Chem. 2003;278:3153-3161.
41. Harder T, Scheiffele P, Verkade P, Simons K. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J Cell Biol. 1998;141:929-942.
42. Roper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol. 2000;2:582-592.
43. Gomez-Mouton C, Abad JL, Mira E, et al. Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization. Proc Natl Acad Sci U S A. 2001;98:9642-9647.
44. Moore JP, Stevenson M. New targets for inhibitors of HIV-1 replication. Nat Rev Mol Cell Biol. 2000;1:40-49.